Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
Monster Beverage
MNST
|
+$584M |
| 3 |
Intercontinental Exchange
ICE
|
+$534M |
| 4 |
Applied Materials
AMAT
|
+$386M |
| 5 |
Johnson & Johnson
JNJ
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.95B |
| 2 |
Texas Instruments
TXN
|
+$750M |
| 3 |
Deere & Co
DE
|
+$539M |
| 4 |
Microsoft
MSFT
|
+$507M |
| 5 |
Meta Platforms (Facebook)
META
|
+$488M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.99% |
| 2 | Healthcare | 19.86% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.49% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
201
DELISTED
Avadel Pharmaceuticals
AVDL
| $175M | 0.09% |
13,326,887
+29,570
| +0.2% | +$450K |
|
202
Mirum Pharmaceuticals
MIRM
$6.96B
| $175M | 0.09% |
4,480,284
-508,463
| -10% | -$20.3M |
|
203
Structure Therapeutics
GPCR
$3.46B
| $174M | 0.09% |
3,956,878
+602,609
| +18% | +$23.3M |
|
204
Dentsply Sirona
XRAY
$2.61B
| $173M | 0.09% |
6,389,767
-1,172,600
| -16% | -$29.9M |
|
205
Glaukos
GKOS
$8.92B
| $173M | 0.09% |
1,325,784
-131,749
| -9% | -$16.4M |
|
206
Capital One
COF
$127B
| $172M | 0.09% |
1,149,555
-40,527
| -3% | -$5.77M |
|
207
nVent Electric
NVT
$24.1B
| $171M | 0.09% |
2,441,154
+466,042
| +24% | +$32.2M |
|
|
ACLX
208
DELISTED
Arcellx
ACLX
| $168M | 0.09% |
2,011,950
+109,332
| +6% | +$7.28M |
|
209
Apollo Global Management
APO
$71.6B
| $167M | 0.09% |
1,339,355
+4,892
| +0.4% | +$565K |
|
210
Xylem
XYL
$28.6B
| $167M | 0.09% |
1,239,550
-241,763
| -16% | -$32.3M |
|
211
United Therapeutics
UTHR
$26.3B
| $165M | 0.08% |
460,419
+50,409
| +12% | +$17M |
|
212
Western Alliance Bancorporation
WAL
$9.04B
| $164M | 0.08% |
1,896,377
+74,956
| +4% | +$5.77M |
|
213
IDEAYA Biosciences
IDYA
$3.54B
| $164M | 0.08% |
5,162,376
+1,086,356
| +27% | +$41.2M |
|
|
GTLS
214
DELISTED
Chart Industries
GTLS
| $162M | 0.08% |
1,307,823
+41,079
| +3% | +$5.39M |
|
215
AXIS Capital
AXS
$8.63B
| $161M | 0.08% |
2,021,949
-281,011
| -12% | -$21M |
|
216
Williams Companies
WMB
$86.6B
| $158M | 0.08% |
3,468,826
-8,900
| -0.3% | -$391K |
|
217
Micron Technology
MU
$1.02T
| $157M | 0.08% |
1,516,256
+91,469
| +6% | +$9.57M |
|
218
Ziff Davis
ZD
$1.93B
| $156M | 0.08% |
3,214,600
+62,261
| +2% | +$2.97M |
|
219
Vanguard Total International Stock ETF
VXUS
$153B
| $154M | 0.08% |
2,379,351
-2,792
| -0.1% | -$173K |
|
220
Encompass Health
EHC
$11.3B
| $153M | 0.08% |
1,577,719
-2,665
| -0.2% | -$239K |
|
221
Marriott International
MAR
$101B
| $152M | 0.08% |
613,052
+47,551
| +8% | +$11.1M |
|
222
S&P Global
SPGI
$130B
| $150M | 0.08% |
289,480
+13,952
| +5% | +$6.9M |
|
223
Ardelyx
ARDX
$1.25B
| $148M | 0.08% |
21,529,880
-4,419,443
| -17% | -$26.1M |
|
224
Gilead Sciences
GILD
$162B
| $148M | 0.08% |
1,761,561
+98,067
| +6% | +$7.48M |
|
225
Public Storage
PSA
$60.5B
| $146M | 0.07% |
401,157
+3,935
| +1% | +$1.28M |
|
Similar funds
Janus Henderson Group's Q3 2024 Portfolio in Review
As of Q3 2024, Janus Henderson Group held 2,584 positions worth $195B, up 4.6% from $187B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.7%. Janus Henderson Group opened 66 new positions and exited 56, leaving the 2,584-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2024 buy was Janus Henderson Emerging Markets Debt Hard Currency ETF: 4,369,165 shares worth $228M.
- Janus Henderson Group added most to Broadcom in Q3 2024, an estimated $605M increase.
- Janus Henderson Group's biggest Q3 2024 reduction was Texas Instruments, cutting an estimated $750M.
- Janus Henderson Group fully exited Lam Research in Q3 2024, selling an estimated $1.95B.
- Janus Henderson Group's ten largest holdings make up 30% of its $195B portfolio in Q3 2024.
- Janus Henderson Group opened 66 new positions and closed 56 in Q3 2024.
- Janus Henderson Group's portfolio value rose 4.6% quarter-over-quarter to $195B.
Based on Janus Henderson Group's 13F filing for Q3 2024, filed 14 Nov 2024.